Clinical Trial Update: The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the role of concurrent chemotherapy for lower risk locally advanced nasopharyngeal carcinoma in the IMRT era.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: UNKNOWN